Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
PERCEPTIVE ADVISORS LLC | 1,829,735 9.500% |
710,700 (+63.51%) |
Filing History |
| 2025-02-14 4:15 pm Sale |
2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 4,731,150 5.100% |
-3,230,997 (-40.58%) |
Filing History |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Anteris Technologies Global Corp. AVR |
PERCEPTIVE ADVISORS LLC | 2,440,000 6.700% |
2,440,000 (New Position) |
Filing History |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Adagio Medical Holdings, Inc. ADGM |
PERCEPTIVE ADVISORS LLC | 15,321,655 73.600% |
64,167 (+0.42%) |
Filing History |
| 2025-02-14 4:15 pm Sale |
2024-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
PERCEPTIVE ADVISORS LLC | 22,112,266 7.300% |
-4,505,443 (-16.93%) |
Filing History |
| 2025-01-31 9:06 pm Unchanged |
2025-01-31 | 13D | Nautilus Biotechnology, Inc. NAUT |
PERCEPTIVE ADVISORS LLC | 12,594,211 10.000% |
0 (Unchanged) |
Filing History |
| 2025-01-08 9:28 pm Purchase |
2024-12-31 | 13G | Traws Pharma, Inc. TRAW |
PERCEPTIVE ADVISORS LLC | 386,555 9.900% |
386,555 (New Position) |
Filing History |
| 2024-12-16 9:02 pm Unchanged |
2024-12-12 | 13D | Lyra Therapeutics, Inc. LYRA |
PERCEPTIVE ADVISORS LLC | 12,757,562 19.500% |
0 (Unchanged) |
Filing History |
| 2024-12-09 6:22 pm Purchase |
2024-12-05 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 7,962,147 8.700% |
862,965 (+12.16%) |
Filing History |
| 2024-11-19 9:44 pm Sale |
2024-11-14 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 1,770,792 4.100% |
-1,684,184 (-48.75%) |
Filing History |
| 2024-11-14 9:50 pm Purchase |
2024-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
PERCEPTIVE ADVISORS LLC | 5,435,210 8.600% |
291,635 (+5.67%) |
Filing History |
| 2024-11-14 8:14 pm Purchase |
2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX |
PERCEPTIVE ADVISORS LLC | 1,488,553 9.900% |
1,488,553 (New Position) |
Filing History |
| 2024-11-14 7:59 pm Purchase |
2024-11-14 | 13D | Solid Biosciences Inc. SLDB |
PERCEPTIVE ADVISORS LLC | 6,934,678 17.300% |
6,934,678 (New Position) |
Filing History |
| 2024-11-14 5:26 pm Unchanged |
2024-08-28 | 13D | Trinity Biotech plc TRIB |
PERCEPTIVE ADVISORS LLC | 56,000,000 22.600% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | enVVeno Medical Corporation NVNO |
PERCEPTIVE ADVISORS LLC | 1,869,219 9.900% |
474,503 (+34.02%) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Iovance Biotherapeutics, Inc. IOVA |
PERCEPTIVE ADVISORS LLC | 26,617,709 8.800% |
7,395,966 (+38.48%) |
Filing History |
| 2024-11-14 4:50 pm Sale |
2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
PERCEPTIVE ADVISORS LLC | 2,812,665 3.800% |
-1,209,401 (-30.07%) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 9,275,851 15.600% |
682,265 (+7.94%) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Precision BioSciences, Inc. DTIL |
PERCEPTIVE ADVISORS LLC | 426,293 5.900% |
426,293 (New Position) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Verona Pharma plc VRNA |
PERCEPTIVE ADVISORS LLC | 6,565,933 8.100% |
1,447,788 (+28.29%) |
Filing History |